Recipe for ABEL and adjusted α [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2017-03-23 20:10 (2561 d 15:17 ago) – Posting: # 17181
Views: 4,426

Dear all,

since we published our paper1 about the Type I Error, I received questions about its application, regulatory acceptability, etc. In the following I summarize my answers.Answers to questions not asked:@Detlew: Something wrong or did I forget anything?


  1. Labes D, Schütz H. Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its Control. Pharm Res. 2016;33(11):2805–14. doi:10.1007/s11095-016-2006-1. [image] free full-text view-only.
  2. Zheng C, Wang J, Zhao L. Testing bioequivalence for multiple formulations with power and sample size calculations. Pharm Stat. 2012;11(4):334–41. doi:10.1002/pst.1522


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,639 registered users;
102 visitors (0 registered, 102 guests [including 4 identified bots]).
Forum time: 11:27 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5